What is Xeris Biopharma Holdings, Inc.'s price / book?

Xeris Biopharma Holdings, Inc. (XERS) reported price / book of 76.9× in Q1 2026.

What is the long-term trend for Xeris Biopharma Holdings, Inc.'s price / book?

Over 3 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s price / book has grown at a 73.6% compound annual growth rate (CAGR), from 18.2× to 95.1×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Xeris Biopharma Holdings, Inc. XERS Price / book

Price / book at other companies

Eli LillyLLY

26.3×-20.7×

Corcept TherapeuticsCORT

6.7×-10.9×

Eton Pharmaceuticals, Inc.ETON

22×+7.8×

Ultragenyx PharmaceuticalRARE

316.5×+303×

Zevra Therapeutics, Inc.ZVRA

2.7×-7.2×

ANI PharmaceuticalsANIP

3.1×-0.4×

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+76.9%

Enterprise value$1.42B+52.7%

P/E106.4×—

P/S4.1×+0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.

market cap/total stockholders equity=76.9×

Based on the most recent quarter.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s price / book?: Xeris Biopharma Holdings, Inc. (XERS) reported price / book of 76.9× in Q1 2026.
What is the long-term trend for Xeris Biopharma Holdings, Inc.'s price / book?: Over 3 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s price / book has grown at a 73.6% compound annual growth rate (CAGR), from 18.2× to 95.1×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.